European Journal of Cardiovascular Medicine

According to World Health Organization reports, the global prevalence of diabetes was estimated to be 9% among adults aged ≥18 years in 2014, and hence about 347 million people around the world have the disease.

Tinea corporis, also known as ‘ringworm,’ is a superficial dermatophyte infection of the skin, other than on the hands (tinea manuum), feet (tinea pedis), scalp (tinea capitis), bearded areas (tinea barbae), face (tinea faciei), groin (tinea cruris), and nails (onychomycosis or tinea unguium).1 Tinea corporis is most commonly caused by dermatophytes belonging to one of the three genera, namely, Trichophyton (which causes infections  There are certain risk factors like age, sex, status of diabetes influence the occurrence of  Tinea Corporis among diabetes. on skin, hair, and nails), Microsporum (which causes infections on skin and hair), and Epidermophyton (which causes infections on skin and nails).1–3

Dermatophytes are grouped as either anthropophilic, zoophilic, or geophilic, depending on whether their primary source is human, animal, or soil, respectively.4,5 Because tinea corporis is common and many other annular lesions can mimic this fungal infection, physicians must familiarize themselves with its etiology and its treatment.

Tinea corporis is the most common dermatophytosis [41]. While tinea corporis occurs worldwide, it is most commonly observed in tropical regions [42]. The lifetime risk of acquiring tinea corporis is estimated to be 10–20%.6 Tinea corporis occurs most frequently in post-pubertal children and young adults.[18,43,44] Rare cases have been reported in the newborn period.[45] There is no sex predominance.1 Humans may become infected through close contact with an infected individual, an infected animal (in particular, domestic dog or cat), contaminated fomites, or contaminated soil.[46–48 ]Infection may be acquired as a result of spread from another site of dermatophyte infection (e.g. tinea capitis, tinea pedis, onychomycosis).[49,50]  

Diabetes can cause complications that affect all systems of the body. However, such complications mainly refer to the compromising of the vascular and immune systems and of peripheral neuropathy, and hence diabetes patients are particularly susceptible to fungal infection3 Gupta et al.

Aims & Objectives

To study Prevalence of Tinea Corporis in general population and evaluate its association with Diabetes patient

We Conducted Cross sectional study to Find out the prevalence of  Tinea Corporis in general population  and its association with  Diabetes patient among general population by using self-report questionnaire  Written consent has been taken from all the participants before starting study .Total 60 peoples participated through random sampling method.

Cross sectional study method was used in this study. We included the various variables   to explore the relationship between Tinea Corporis and Diabetes patient .Here we used the lottery method to exclude biased. Participants who are more than 18 years old are included in this study.

We conducted community‑based, Cross Sectional study. For we started random sampling procedure among general population and selected participants are included in this study from beginning June 1, 2024- to December 2024. Before stared the study we already taken the approval from the institutional review board IIMSAR, Haldia

Study Population

All diabetic mellitus patients attending diabetic OPD.

Included Criteria

Patients above 18 years of age and who are known diabetic on treatment attending diabetic OPD were included in the study.

Exclusion Criteria

Patients below 18 years of age and patients having secondary diabetes were excluded from the study.

Patients with obesity, hypothyroidism, causing peripheral neuropathy including familial causes.

Sample Size

Participants with Diabetic are   above inclusion and exclusion criteria- 60 cases were selected randomly. Ethical committee clearance was obtained from the Institutional Ethical Committee.

Detailed history regarding the diabetic history, treatment history, duration of the illness, symptoms relating to neuropathy confined to upper limb or lower limb. History of hemodialysis previously was obtained

In our study Table no 1 it was found that prevalence of Tinea corporis is 63.3%.

In our study total participants. Among them majority of participants were suffered of  Tinea Corporis  63.3% , then 16%people were suffered of  pityriasis Alba, 10% were suffered of   Dermatitis and  6.6% were suffered of Psoriasis. And only 3.3% were found Vitiligo among General Population.

The present study was conducted to find out the prevalence of the Tinea Corporis and diabetic patient. Among the study population of 60, 63% were in the age group between 41 and 60 (Table 2).

Association of Diabetes with Tinea Corporis  

Table No2: -Age Distribution in Diabetic Patient

36.33% were female and 63.33% were male in the study population. Nearly 92% were belonging to Type 2 Diabetes mellitus. Male participants are more prone to diabetes as compared to female participant. .About 59% were not under control of diabetes as per the records and also according to HbA1c. Among 60 diabetes patients 21 (19.8%) people were suffering from carpal tunnel syndrome.

The occurrence of Tinea Corporis was 18.6% among diabetes mellitus according but clinical assessment has identified only 11.3%. The routine  study has found the prevalence of Tinea Coporis was 66.6% in india. The Tinea Corporis  found is in 21% of the female compare to 7% among male, this increase occurrence in female was statistically significant. There was statistical significant association between symptoms of the disease and presence of disease (Table 3).

Table 3:- Gender  wise distribution of  Tinea Corporis

Fig 3: - Gender wise distribution of Tinea Corporis

The disease was more among the people who did not have control of diabetes and it was statistically significant as shown in Table 4.  It has  been seen that that uncontrol diabetes patient are  more suffered of  Tinea Corporis  as compare of control group of diabetic patient .here my study Odd ratio is Odds Ratio=3.55,  95% CI = 1.1940 to 10.58 , Chi Square =2.278 , P value <0.022 . Here P value is less that 0.05 s0 it is statistically significant. So Diabetic patient have more chances of Carpel tunnel syndrome as compared to no diabetic patient.

Odds Ratio=3.55, 95% CI = 1.1940 to 10.

Diabetes is one of the Contribution factors for Tinea Corporis.

The occurrence of Tinea Corporis among one fourth of the diabetes patients is proved by various studies. This problem along with other complication also gives burden on the patients. The uncontrolled diabetes rather than duration of the diabetes is also major cause for the Tinea Corporis. It is the duty of the physician and the patient to control the diabetes to prevent the Tinea Corporis.  Fungal skin and nail infections of the feet, such as tinea Corporis and onychomycosis, were significantly more frequent in diabetes patients, and the development of tinea Corporis in these patients was significantly associated with increasing age and male gender

The prevalence of   Tinea Corporis among in Diabetic patients in IIMSAR Haldia is 63.33%. The result of the present study also showed that the Males are more affected than Females

Conflict of interest

There is no any Conflict Of interest.

Submission declaration

This submission has not been published anywhere previously and that it is not simultaneously being considered for any other

1. World Health Organization. Global Health Estimates: Deaths by Cause, Age, Sex and Country, 2000–2012. Geneva: WHO, 2014.
2. Cathcart S, Cantrell W, Elewski B. Onychomycosis and diabetes. J Eur Acad Dermatol Venereol 2009; 23: 1119– 1122
3. Singh S, Verma P, Chandra U, Tiwary N. Risk factors for chronic and chronic-relapsing tinea corporis, tinea cruris and tinea faciei: Results of a case–control study. Indian Journal of Dermatology, Venereology and Leprology. 2019 Mar 1;85(2):197-200.
4. Das NK, Ghosh P, Das S, Bhattacharya S, Dutta RN, Sengupta SR. A study on the etiological agent and clinico-mycological correlation of fingernail onychomycosis in eastern India. Indian journal of dermatology. 2008;53(2):75.
5. Vineetha M, Sheeja S, Celine MI, Sadeep MS, Palackal S, Shanimole PE, Das SS. Profile of dermatophytosis in a tertiary care center in Kerala, India. Indian journal of dermatology. 2019 Jul;64(4):266.
6. Jegadeesan M, Kuruvila S, Nair S. Clinico-etiological Study of Tinea Corporis: Emergence of Trichophyton mentagrophyte. Int J Sci Stud 2017;5(1):161-165
7. Paget J. Lectures on surgical pathology. Philadelphia: Lindsay and Blakiston 1854.

8. Alfonso C, Jann S, Massa R, Torreggiani A. Diagnosis, treatment and follow-up of the carpal tunnel syndrome: a review. Neurolog Sci 2010; 31(3): 243-52.
9. American Academy of Orthopaedic Surgeons Work Group Panel. Clinical guidelines on diagnosis of carpal tunnel syndrome, 2007.
10. Amirlak B, Upadhyaya K, Ahmed O, Wolff T, Tsai T, Scheker L. Median Nerve Entrapment. 1-11-2010. Internet Communication. [Accessed: 24/10/2011]. Padua L, LoMonaco M, Padua R. Neurophysiological classification of carpal tunnel syndrome: assessment of 600 symptomatic hands. Ital J Neurol Sci 1997; 18: 145-50.
11. INAIL: Italian Worker's Compensation Authority, Annual Report 2000. Available at: http://www.inail.it/cms/multilingua/inglese/rap portoannuale2001/RappAnn2000RelPresInglese.pdf [Accessed: 24/ 10/2011]. [7] Lo SL, Raskin K, Lester H, Lester B. Carpal tunnel syndrome: a historical perspective. Hand Clin 2002; 18(2): 211-7.
12. Pfeffer GB, Gelberman RH, Boyes JH, Rydevik B. The history of carpal tunnel syndrome. J Hand Surg Br 1988; 13(1): 28-34.
13. Aroori S, Spence RA. Carpal tunnel syndrome. [Review] [135 refs]. Ulster Medical J 2008; 77(1): 6-17.
14. Burns TM. Mechanisms of acute and chronic compression neuropathy. In: Dyck PJ, Thomas PK, Eds. Peripheral neuropathy. 4th ed. Amsterdam: Elsevier 2005; pp. 1391-402.
15. Danielsson LG. Iatrogenic pronator syndrome: case report. Scand J Plast Reconstr Surg 1980; 14(2): 201-3.
16. Hartz CR, Linscheid RL, Gramse RR, Daube JR. he pronator teres syndrome: compressive neuropathy of the median nerve. J Bone Joint Surg Am 1981; 63(6): 885-90.
17. Rask MR. Anterior interosseous nerve entrapment: (Kiloh-Nevin syndrome) report of seven cases. Clin Orthop Relat Res 1979; (142): 176-81. [14] Atroshi I, Gummesson C, Johnsson R, Ornstein E, Ranstam J, Rosen I. Prevalence of carpal tunnel syndrome in a general population. JAMA 1999; 282(2): 153-8.
18. Uchiyama S, Itsubo T, Nakamura K, Kat H, Yasutomi T, Momose T. Current concepts of carpal tunnel syndrome: pathophysiology, treatment, and evaluation. J Orthop Sci 2010; 15: 1-13.
19. Mondelli M, Giannini F, Giacchi M. Carpal tunnel syndrome incidence in a general population. Neurology 2002; 58: 289-94. Phalen GS. The carpal-tunnel syndrome. J Bone and Joint Surg Am 1966; 48(A): 380-3.
20. European Agency for Safety and Health at Work. Work related neck and upper limb musculoskeletal disorders. Office for Official Publication of the European Communities, Luxembourg 1999.
21. Monograph containing 87 methods of analysis, studies and experiences for prevention of musculoskeletal disorders of the upper limb biomechanical overload. J Occup Med 1996.
22. Veraldi S, Genovese G, Peano A. Tinea corporis caused by Trichophyton equinum in a rider and review of the literature. Infection. 2018;46(1):135–137. https://doi.org/10.1007/s15010-017-1067-3

23. Poudyal Y, Joshi SD. Medication practice of patients with dermatophytosis. JNMA J Nepal Med Assoc. 2016;55(203):7–10. https://doi.org/10.31729/jnma.2830
24. Ebrahimi M, Zarrinfar H, Naseri A, et al. Epidemiology of dermatophytosis in Northeastern Iran: a subtropical region. Curr Med Mycol. 2019;5(2):16–21. https://doi.org/10.18502/cmm.5.2.1156
25. Ely JW, Rosenfeld S, Seabury Stone M. Diagnosis and management of tinea infections. Am Fam Physician. 2014;90(10):702–710. PMID: 25403034
26. Leung AKC, Barankin B. An itchy, round rash on the back of an adolescent’s neck. Consultant for Pediatricians. 2014;13:466–469. https://www.consultant360.com/articles/itchy-round-rash-back-adolescent-s-neck. Accessed June 22, 2020.
27. Palit A, Inamadar AC. Annular, erythematous skin lesions in a neonate. Indian Dermatol Online J. 2012;3(1):45–47. https://doi.org/10.4103/2229-5178.93504 46. Andrews MD, Burns M. Common tinea infections in children. Am Fam Physician. 2008;77(10):1415–1420. PMID: 18533375.
28. Czaika VA. Misdiagnosed zoophile tinea faciei and tinea corporis effectively treated with isoconazole nitrate and diflucortolone valerate combination therapy. Mycoses. 2013;56(Suppl. 1):26–29. https://doi.org/10.1111/myc.12057
29. Nenoff P, Kruger C, Ginter-Hanselmayer G, Tietz HJ. Mycology – an update. Part 1: dermatomycosis: causative agents, epidemiology and pathogenesis. J Dtsch Dermatol Ges. 2014;12(3):188–209. https://doi.org/10.1111/ddg.12245
30. Leung AKC, Lam JM, Leong KF. Childhood solitary cutaneous mastocytoma: clinical manifestations, diagnosis, evaluation, and management. Curr Pediatr Rev. 2019;15(1):42–46. https://doi.org/10.2174/1573396315666181120163952
31. Leung AKC, Lam JM, Leong KF, et al. Onychomycosis: an updated review. Recent Pat Inflamm Allergy Drug Discov. 2020;14(1):32–45. https://doi.org/10.2174/1872213X13666191026090713
32. Yin B, Xiao Y, Ran Y, Kang D, Dai Y, Lama J. Microsporum canis infection in three familial cases with tinea capitis and tinea corporis. Mycopathologia. 2013;176(3–4):259–265. https://doi.org/10.1007/s11046-013-9685-5
33. Gupta AK, Chaudhry M, Elewski B. Tinea corporis, tinea cruris, tinea nigra, and piedra. Dermatol Clin. 2003;21(3):395–400. https://doi.org/10.1016/s0733-8635(03)00031-7
34. Leung AKC, Leong KF, Lam JM. Tinea imbricata: an overview. Curr Pediatr Rev. 2019;15(3):170–174. https://doi.org/10.2174/1573396315666190207151941
35. Qadim HH, Golforoushan F, Azimi H, Goldust M. Factors leading to dermatophytosis. Ann Parasitol. 2013;59(2):99–102. PMID: 24171304.
36. Singh S, Verma P, Chandra U, Tiwary NK. Risk factors for chronic and chronic-relapsing tinea corporis, tinea cruris and tinea faciei: results of a case-control study. Indian J Dermatol Venereol Leprol. 2019;85(2):197–200. https://doi.org/10.4103/ijdvl.IJDVL_807_17
37. Shy R. Tinea corporis and tinea capitis. Pediatr Rev. 2007;28(5):164–173. https://doi.org/10.1542/pir.28-5-164
38. Leung AKC. Tinea corporis. In: Leung AKC, ed. Common Problems in Ambulatory Pediatrics: Specific Clinical Problems, volume 2. New York: Nova Science Publishers, Inc.; 2011:19–22. 58. Kaushik N, Pujalte GG, Reese ST. Superficial fungal infections. Prim Care. 2015;42(4):501–516. https://doi.org/10.1016/j.pop.2015.08.004
39. Weinstein A, Berman B. Topical treatment of common superficial tinea infections. Am Fam Physician. 2002;65(10):2095–2102. PMID: 12046779.
40. Ziemer M, Seyfarth F, Elsner P, Hipler UC. Atypical manifestations of tinea corporis. Mycoses. 2007;50(Suppl. 2):31–35.
41. Panthagani AP, Tidman MJ. Diagnosis directs treatment in fungal infections of the skin. Practitioner. 2015;259(1786):25–29, 3. PMID: 26738249 
42. Bachmeyer C, Buot G. Tinea corporis in a mixed martial arts fighter. CMAJ. 2013;185(10):897. https://doi.org/10.1503/cmaj.120813
43. Hiruma J, Ogawa Y, Hiruma M. Trichophyton tonsurans infection in Japan: epidemiology, clinical features, diagnosis and infection control. J Dermatol. 2015;42(3):245–249. https://doi.org/10.1111/1346-8138.12678
44. Kermani F, Moosazadeh M, Hedayati MT, et al. Molecular epidemiology of tinea gladiatorum in contact sports in northern Iran. Mycoses. 2020;63(5):509–516. https://doi.org/10.1111/myc.13069
45. McClanahan C, Wanat K. Tinea corporis in a wrestling team cheerleader. Int J Womens Dermatol. 2016;2(4):143–144. https://doi.org/10.1016/j.ijwd.2016.10.001 66. Wilson EK, Deweber K, Berry JW, Wilckens JH. Cutaneous infections in wrestlers. Sports Health. 2013;5(5):423–437.